Author

Darshna K. Lakhnotra

Observed names: Darshna K. Lakhnotra, Lakhnotra, Darshna K.

Institution: Shri Govind Guru University

Observed institution: Shri Govind Guru University

ORCID: 0009-0005-0953-2585

Observed ORCID: 0009-0005-0953-2585

OpenAlex ID: A5117127252

Synthesis, spectroscopic characterization, and DFT-assisted molecular docking analysis of novel 1,3,4-oxadiazole–1,2,3-triazole hybrids with antimicrobial and cytotoxicity potential

2026 · Darshna K. Lakhnotra, Jay B. Maheta, et al. · RSC Advances · 26

Computational and Experimental Insights into the Anticancer as Well as Antimicrobial Activity of Coumarin‐1,2,3‐Triazole Derivatives: A Study Based on DFT, Docking, ADME, and In Vitro Assays

2025 · Nargis H. Shaikh, Jay B. Maheta, et al. · ChemistrySelect · 21

Design, Synthesis, and Anticancer Evaluation of Novel Coumarin-1,3,4-Thiadiazole-Chalcone Hybrids as Dual EGFR/VEGFR2 Inhibitors: Molecular Docking, DFT, and ADMET Studies

2026 · Dushyant V. Pathak, Jay B. Maheta, et al. · Polycyclic aromatic compounds · 16

Design and synthesis of benzofuran–pyrazole–triazole hybrids via click chemistry: Antimicrobial, anticancer, ADMET, docking, and DFT studies

2026 · Ila M. Ram, Jay B. Maheta, et al. · Synthetic Communications · 10

In silico DFT, ADMET and molecular docking studies of novel coumarin-linked pyrazole and quinoline derivatives as antimicrobial and antioxidant agents

2026 · Nargis H. Shaikh, Jay B. Maheta, et al. · Scientific Reports · 8

Author response for "Rational Design and Synthesis of Furan-Based Schiff Base Quinazolin-4-amine Hybrids: Spectral Elucidation, Molecular Docking, DFT Studies, and In Silico ADMET-Antioxidant study"

2026 · Sunil D. Narode, Miral Vora, et al. · Publons reviews and discussion

Design, synthesis and dual anticancer and antibacterial evaluation of novel 1,3,4-oxadiazole-2-thiol derivatives targeting EGFR and DNA Gyrase B: integrated docking, DFT and ADMET studies

2026 · Ila M. Ram, Jay B. Maheta, et al. · Future Medicinal Chemistry

Design, synthesis and dual anticancer and antibacterial evaluation of novel 1,3,4-oxadiazole-2-thiol derivatives targeting EGFR and DNA Gyrase B: integrated docking, DFT and ADMET studies

2026 · Ila M. Ram, Jay B. Maheta, et al. · Figshare

Novel Benzo[b][1,5] naphthyridine–Arylhydrazone Hybrids as EGFR-Targeted Anticancer Agents: Synthesis, DFT, and MCF-7 Antiproliferative Evaluation

2026 · Jay B. Maheta, Darshna K. Lakhnotra, et al. · Research Square

Design and synthesis of benzofuran–pyrazole–triazole hybrids via click chemistry: Antimicrobial, anticancer, ADMET, docking, and DFT studies

2026 · Ram, Ila M., Maheta, Jay B., et al. · Figshare

Design, Synthesis, and Anticancer Evaluation of Novel Coumarin-1,3,4-Thiadiazole-Chalcone Hybrids as Dual EGFR/VEGFR2 Inhibitors: Molecular Docking, DFT, and ADMET Studies

2026 · Dushyant V. Pathak, Jay B. Maheta, et al. · Figshare

Potential c-Met-targeted pyrazole–pyridine–oxadiazole hybrids: synthesis, anticancer activity, and computational rationale

2026 · Prince A. Dave, Jay B. Maheta, et al. · Organic & Biomolecular Chemistry

Design, synthesis, and anticancer evaluation of Biginelli-derived DHPM–amide hybrids bearing clinically inspired kinase-directed pharmacophores: EGFR docking and DFT studies

2026 · Sagar P. Kothadiya, Jay B. Maheta, et al. · RSC Advances

Rational design and synthesis of furan-based Schiff base quinazolin-4-amine hybrids: spectral elucidation, molecular docking, DFT studies, and in silico ADMET-antioxidant study

2026 · Sunil D. Narode, Miral Vora, et al. · RSC Advances

"Triazole-Oxadiazole-Based Schiff Bases as Potential Kinase Inhibitors: Synthesis, Dft Studies, Molecular Docking and Anticancer Evaluation"

2025 · Yogesh Bhola, Jay B. Maheta, et al. · SSRN Electronic Journal

Works count: 17

Citation count: 127

H-index: 7

I10-index: 6